Quantifying Bioactivity on a Large Scale: Quality Assurance and Analysis of Multiparametric Ultra-HTS Data
Open Access
- 1 August 2005
- journal article
- other
- Published by SAGE Publications in SLAS Technology
- Vol. 10 (4) , 207-212
- https://doi.org/10.1016/j.jala.2005.05.003
Abstract
There is a growing need to precisely quantify the selectivity of large compound sets in high throughput screening, directing investment in lead optimization towards compounds with a high chance of success. High-content, high-density screening technologies such as multiparametric ultra-HTS provide a basis for highly precise screening with unprecedented scope for delineating process artifacts from reliable signals. However, the full potential of these technologies can only be realized with suitable experimental design and sophisticated data analysis tools. We present two advanced analysis workflows demonstrating how multiparametric readouts from a high throughput primary screen can improve decision quality in the hit identification process. The first involves discrete thresholding and the application of multiple selection criteria. The second uses machine learning algorithms and allows an unbiased consideration of all measured parameters.Keywords
This publication has 5 references indexed in Scilit:
- Development and Implementation of a Highly Miniaturized Confocal 2D-FIDA–Based High-Throughput Screening Assay to Search for Active Site Modulators of the Human Heat Shock Protein 90βSLAS Discovery, 2004
- Molecular Informatics as an Enabling in silico Technology Platform for Drug DiscoveryChimia, 2004
- Experiences in Implementing uHTS - Cutting Edge Technology Meets the Real WorldCurrent Drug Discovery Technologies, 2004
- Two-Dimensional Fluorescence Intensity Distribution Analysis: Theory and ApplicationsBiophysical Journal, 2000
- Fluorescence correlation spectroscopy: lead discovery by miniaturized HTSDrug Discovery Today, 1998